Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Where have all the torsos gone? The photorealistic “clinch cover,” featuring lovers mid-embrace, is a critically endangered species. Fabio? Hasn’t been seen around these parts in years. But he hasn’t ...

In 2025’s volatile macro environment, gold has surged in popularity amid rising geopolitical tensions and a weaker U.S.

Romance novels thrive on familiarity and the promise of a happily ever after (or a happy for now), and their covers likewise ...

The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate ...